Centre for Genomic Pathogen Surveillance Partnering for COVID-19

News article by the Centre for Genomic Pathogen Surveillance — 27 April 2020

Pathogen surveillance is a crucial part of early-stage and ongoing responses to COVID-19. The UK consortium on COVID-19 genomics (COG) aims to link local sequencing centres with large scale facilities from across the UK to apply real-time genomic epidemiology to our understanding and ability to respond to the pandemic.

We are excited to be a core partner in COG (cogconsortium.uk) delivering large-scale and rapid whole-genome virus sequencing to inform UK response.

The Government and the UK’s Chief Scientific Adviser have backed the UK’s leading clinicians and scientists to map how COVID-19 spreads and evolves using whole-genome sequencing. Through a £20 million investment, the consortium will look for breakthroughs that help the UK respond to this and future pandemics, and save lives.

Samples from confirmed cases will be sent to a network of sequencing centres around the country including Cardiff, edinburgh, belfast, Birmingham, Exeter, Glasgow, Liverpool, London, Norwich, Nottingham, Oxford and Sheffield with The Wellcome Trust Sanger Institute providing large-scale capacity and additional support.

Data Analysis, phylogenetics and delivery of insight for decision making will be a key component and deliverable of the project

The CGPS team bring expertise in data handling, processing, linking and visualisation to enhance delivery of data and interpretation using tools such as Microreact, EpiCollect and Data-flo.